IL127295A - Liquisolid systems and methods of preparing same - Google Patents

Liquisolid systems and methods of preparing same

Info

Publication number
IL127295A
IL127295A IL12729596A IL12729597A IL127295A IL 127295 A IL127295 A IL 127295A IL 12729596 A IL12729596 A IL 12729596A IL 12729597 A IL12729597 A IL 12729597A IL 127295 A IL127295 A IL 127295A
Authority
IL
Israel
Prior art keywords
liquid
powder
carrier
liquisolid
coating
Prior art date
Application number
IL12729596A
Other languages
English (en)
Other versions
IL127295A0 (en
Original Assignee
Spireas Spiridon
Bolton Sanford M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24641555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127295(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Spireas Spiridon, Bolton Sanford M filed Critical Spireas Spiridon
Publication of IL127295A0 publication Critical patent/IL127295A0/xx
Publication of IL127295A publication Critical patent/IL127295A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
IL12729596A 1996-06-10 1997-06-09 Liquisolid systems and methods of preparing same IL127295A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,514 US5800834A (en) 1996-06-10 1996-06-10 Liquisolid systems and methods of preparing same
PCT/US1997/010093 WO1997047290A1 (en) 1996-06-10 1997-06-09 Liquisolid systems and methods of preparing same

Publications (2)

Publication Number Publication Date
IL127295A0 IL127295A0 (en) 1999-09-22
IL127295A true IL127295A (en) 2002-05-23

Family

ID=24641555

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12729596A IL127295A (en) 1996-06-10 1997-06-09 Liquisolid systems and methods of preparing same

Country Status (12)

Country Link
US (2) US5800834A (ja)
EP (1) EP0946154B1 (ja)
JP (1) JP2000512295A (ja)
CN (1) CN1224379C (ja)
AT (1) ATE486584T1 (ja)
BR (1) BR9709778A (ja)
CA (1) CA2257890C (ja)
DE (1) DE69740040D1 (ja)
ES (1) ES2355871T3 (ja)
IL (1) IL127295A (ja)
RU (1) RU2209623C2 (ja)
WO (1) WO1997047290A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
DE69942205D1 (de) 1998-08-13 2010-05-12 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
EP1140027B1 (en) * 1998-12-23 2005-10-12 Alza Corporation Dosage forms comprising porous particles
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
WO2001052818A1 (en) 2000-01-19 2001-07-26 Pharmaceutical Discovery Corporation Dry powder formulations of antihistamine for nasal administration
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US7056951B2 (en) 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6692771B2 (en) 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
AU2001241730B2 (en) * 2001-02-23 2007-03-15 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
KR101170844B1 (ko) * 2003-02-24 2012-08-02 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
US20050181059A1 (en) * 2003-09-30 2005-08-18 Spherics, Inc. Nanoparticulate therapeutic biologically active agents
WO2005087204A1 (en) 2004-03-08 2005-09-22 Spiridon Spireas Bioavailable solid dosage forms of metaxalone
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
EP1791520A2 (en) * 2004-08-19 2007-06-06 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
FR2894822B1 (fr) * 2005-12-20 2011-11-18 Pf Medicament Composition pharmaceutique contenant des acides gras omega-3
US7569612B1 (en) 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
US10004682B2 (en) 2010-08-24 2018-06-26 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
CN102949363A (zh) * 2012-11-28 2013-03-06 山东省中医药研究院 熊果酸液固压缩片
EP2950923B1 (en) 2013-02-01 2022-03-09 W.R. Grace & CO. - CONN. Porous silica gel as a carrier for liquid technologies
GB201812022D0 (en) 2018-07-24 2018-09-05 Univ Of Sussex Pharmaceutical methods and compositions
EP4076501A4 (en) 2019-12-16 2024-05-08 Rutgers, the State University of New Jersey CONTINUOUS PROCESSES FOR MANUFACTURING IMPREGNATED POROUS SUPPORTS AND FOR MANUFACTURING IMPREGNATED POROUS SUPPORTS CONTAINING PHARMACEUTICAL PRODUCTS
US10744137B1 (en) * 2020-01-06 2020-08-18 King Abdulaziz University Liquisolid tablet containing combined dose of tadalafil and dapoxetine
CN111067875B (zh) * 2020-01-16 2021-11-30 兰州大学 一种阿苯达唑液固压缩片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368112A (en) * 1971-09-08 1974-09-25 Geistlich Soehne Ag Chemical compositions for the treatment of hyperlipemia
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten

Also Published As

Publication number Publication date
CN1224379C (zh) 2005-10-26
WO1997047290A1 (en) 1997-12-18
ATE486584T1 (de) 2010-11-15
JP2000512295A (ja) 2000-09-19
CA2257890C (en) 2003-10-28
EP0946154B1 (en) 2010-11-03
RU2209623C2 (ru) 2003-08-10
HK1022844A1 (en) 2000-08-25
AU3387097A (en) 1998-01-07
CN1221337A (zh) 1999-06-30
EP0946154A4 (en) 2007-02-07
ES2355871T3 (es) 2011-03-31
DE69740040D1 (de) 2010-12-16
US5968550A (en) 1999-10-19
AU709566B2 (en) 1999-09-02
IL127295A0 (en) 1999-09-22
US5800834A (en) 1998-09-01
BR9709778A (pt) 2000-01-11
EP0946154A1 (en) 1999-10-06
CA2257890A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
US5800834A (en) Liquisolid systems and methods of preparing same
US6423339B1 (en) Liquisolid systems and methods of preparing same
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
EP3102186B1 (en) Donepezil compositions and method of treating alzheimer's disease
Khalid et al. Formulation and evaluation of rofecoxib liquisolid tablets
FI96095B (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
US9387191B2 (en) Ferric citrate dosage forms
Priya et al. Liquisolid technique an approach for enhancement of solubility
KR930008956B1 (ko) 서방형 이부프로펜 제제의 제조방법
DK2217241T3 (en) WATER GRANULATION USING A WATER COMPLEX GENERATOR
JP4532903B2 (ja) 微粒子組成物
AU709566C (en) Liquisolid systems and methods of preparing same
WO2010046418A1 (en) Pharmaceutical composition comprising levetiracetam
Chowdary et al. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with β-cyclodextrin
KR100490094B1 (ko) 액상/고상시스템및그제조방법
Altememy et al. Formulation and evaluation of meloxicam liquisolid compact
HK1022844B (en) Liquisolid systems and methods of preparing same
EP0443027B1 (en) Drug composition
MXPA98010456A (en) Liquisolid systems and methods to prepare losmis
Biju Preparation and assessment of clomiphene citrate liquisolid tablets for solubility enhancement
US6077535A (en) Direct compression carbonyl iron tablet
Jones et al. Matrix forming capabilities of three calcium diluents
Ogaji et al. Binding effects of two brands of pregelatinised starch on acetaminophen tablets in a wet granulation process
Sharma et al. FORMULATION, OPTIMIZATION AND EVALUATION OF EXTENDED RELEASE TABLET OF CYANOCOBALAMIN BY USING POLYMER MATRIX SYSTEM
Patel et al. Liquisolid technology: a novel approach to enhance solubility of poorly water soluble drugs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired